ifosfamide has been researched along with Plasmablastic Diffuse Large B-cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dittus, C | 1 |
| Miller, JA | 1 |
| Wehbie, R | 1 |
| Castillo, JJ | 1 |
1 other study available for ifosfamide and Plasmablastic Diffuse Large B-cell Lymphoma
| Article | Year |
|---|---|
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Huma | 2022 |